You are here
Home > News > Greece Opens First Medical Pot Production Plant

Greece Opens First Medical Pot Production Plant

Last Thursday, Greece made history by inaugurating the first medical marijuana plant.

The following is an extract from the Greek ReporterThe investment by Tikun Europe (a subsidiary of Tikun Olam, an Israeli-based company that produces medical marijuana) was able to back the opening of the Corinth plant.

Adonis Georgiadis, Greece’s minister for development and investments, heralded the opening of the plant as a milestone for the country.

Speaking at an event for the opening of the Tikun plant on Thursday, Georgiadis said that cannabis could be “a product which we will be able to export throughout Europe because this factory can carry out huge exports to all major European countries,” as quoted by the Greek Reporter.

According to the outlet, Tikun Europe CEO Nikos Beis hailed the new facility in Greece as “the largest pharmaceutical facility in the industry in Europe.”

“A new era is beginning for our country with the operation of our Tikun Europe facility, paving the way for Greece to become one of the main players in the field of production and export of medical cannabis products,” Beis said, as quoted by the Greek Reporter.

Corinth, Greece: The medicinal cannabis plant. Credit: Tikun Olam

Greece legalized medical cannabis back in 2017, but the country’s government banned the import of such products in 2021, which effectively made it impossible for Greek patients to receive the cannabis treatment due to the lack of domestic production 

However, this seems to be changing.

According to the government, cannabis will soon be sold at pharmacies in Greece.

“The goal is for Greece to become the top European country in the production of medical cannabis. Greece’s environment is friendly for this particular plant and we think we will have a natural advantage,” Georgiadis told the Greek Reporter last year, which said that “foreigners will also be able to use medical cannabis in Greece” and will “be allowed to purchase it through pharmacies” so long as they have a prescription from their doctor.

The outlet reported at the time that Georgiadis anticipated “huge investments in the production of medical cannabis which the government hopes would add up to 1.5 billion euros ($1.67 billion) annually to state revenue.” 

The Greek ReporterMore information about the facility is available here:

“According to Tikun Europe, the plant can produce finished medicinal cannabis products in various pharmaceutical forms. In order to start cultivation immediately in the greenhouse, which has a 21,000m2 area and a 10 Ton annual production, the company plans to plant the cannabis plants. Plants will be propagated under specific protocols to preserve the distinctive characteristics of mother plants for future generations. The facility is expected to reach its full capacity levels gradually in the near future, to deliver a wide variety of finished medical cannabis dosage forms.”

Tikun obtained its license last year to operate the facility. 

“It was a great pleasure to welcome the operating [license] of our production unit, the construction of which was recently completed,” Beis said in a statement at the time. “The operation of the plant will start very soon, bringing us one step closer to the [realization]Our vision is to fulfill the growing demand in Europe and Greece for premium medical cannabis products. Our factory is the largest pharmaceutical company in the specific industry in Europe and exploits the potential of our country to play a leading role in the global market for medical cannabis.”